American Pharma Outsourcing Summit 2017

Sep 27-28, 2017

Boston, MA

Day 1 (September 2711:50 am – 12:25 pm
FLEXIBLE ANTIBODY PRODUCTION IN MULTI-PRODUCT​, SINGLE-USE MODIFIED ​BALLROOM FACILITY
  • Discussing the importance of Process Closure Analysis
  • Closure VPP: Evaluating, documenting and validating closure
  • Leveraging Closure: What is the best operational philosophy​?
  • Case study: Exploring FUJIFILM’s Saturn mAb Facility for f​u​ll product lifecycle production
THOMAS PAGE, PH.D., VP, Engineering and Asset Development, FUJIFILM Diosynth Biotechnologies